TRGC1 and hematologic disorder: Clonal analysis of hematological malignancies including T-LGLL is routinely assessed by polymerase chain reaction (PCR) for T-cell receptor gamma (TCRG) or TCR-beta (TCRB) gene rearrangements or TCRβ repertoire analysis using monoclonal antibodies and flow cytometry (16).